Religare Enterprises announces changes in leadership and enhances governance as part of their FY26 Q4 earnings call. The company has received approval for a demerger that will split into two separate, publicly-traded entities, with the promoter committing to continuous capital infusion.

Religare Enterprises plans to raise INR 1,500 crores in funds to support business expansion. To improve efficiency, the company also intends to undergo a strategic separation (demerger) of its operations.

SEBI has penalized Rashmi Saluja, former chair of Religare, for insider trading, ordering her to return INR 2 crores. The violation occurred when she sold shares worth over 12.9 lakhs before Religare's open offer, thereby evading potential losses of around INR 2 crores.

Religare Enterprises experiences a decline in Q4 net profit, dropping from ₹991 million to ₹822 million year-on-year. Despite the decrease, revenue shows an uptrend with a 22% increase, reaching ₹24.67 billion compared to last year's ₹20.28 billion.

Religare Enterprises Ltd reported a significant increase in Q4 revenue to 422 million INR and overall income of 3.38 billion INR for the fiscal year ending March 31, 2026. Audited results showed no modifications in auditor's opinion.

Religare Enterprises reported a 14.7% increase in revenue for FY26, reaching INR 8,493.8 crores. The profit after tax (PAT) was recorded at INR 73.2 crores. Notably, health insurance premiums surged by 24%, boosting the company's market share to 19.7%. Additionally, broking income stood at INR 373.4 crores.

The tax demand for Religare's subsidiary, CHIL, has been significantly lowered from ₹89.02 crore to ₹45.16 crore. This reduction appears to be a result of corrections made by tax authorities. Notably, CHIL's financials are now consolidated with those of Religare.

Religare Enterprises Ltd has approved a shift of its registered office to Haryana during their Extraordinary General Meeting on May 5, 2026. Arjun Lamba was also appointed as the new Whole-Time Director, following the meeting, chaired by Independent Director Rajender Mohan Malla.

Religare significantly reduced its tax liability for the fiscal years 2022-23, slashing it nearly in half from ₹173.3 crore to ₹86.7 crore. However, the appeal against the initial tax order for this period is still under consideration.

Religare Enterprises Ltd has scheduled an Extraordinary General Meeting (EGM) on May 5th, 2026, for important decisions regarding office relocation to Haryana and the appointment of Arjun Lamba as Executive Director with proposed remuneration. The meeting will be held via Video Conference/Online Annual General Meeting (VC/OAVM).

Religare Enterprises' HR director, Dr. Richa Mishra, is stepping down, effective April 6th, 2026, due to personal commitments. This move follows SEBI regulations.

Religare Health secures a stay from the Bombay High Court on a Rs. 1768 crore GST demand, stemming from disputes over CGST Act regulations. No immediate financial implications have been reported.

The Burman family has significantly increased its holdings in Religare Enterprises, now owning approximately 30.3%, following recent market purchases. To foster growth and enhance shareholder value, Religare is considering a demerger to split its financial services and insurance sectors.